CN116323638A - 订书钉化肽及其方法 - Google Patents

订书钉化肽及其方法 Download PDF

Info

Publication number
CN116323638A
CN116323638A CN202180064601.7A CN202180064601A CN116323638A CN 116323638 A CN116323638 A CN 116323638A CN 202180064601 A CN202180064601 A CN 202180064601A CN 116323638 A CN116323638 A CN 116323638A
Authority
CN
China
Prior art keywords
agent
independently
group
optionally substituted
amino acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN202180064601.7A
Other languages
English (en)
Chinese (zh)
Inventor
布赖恩·哈尔伯特·怀特
司亚光
马丁·罗伯特·特朗布莱
黛博拉·盖尔·康拉迪
章越梅
伊凡·塔克·朱伊特
洛伦佐·若苏埃·阿尔法罗-洛佩斯
莎拉·伊莎贝尔·卡普奇
李志�
约翰·汉尼·麦吉
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Vogel Pharmaceutical Co ltd
Original Assignee
Vogel Pharmaceutical Co ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Vogel Pharmaceutical Co ltd filed Critical Vogel Pharmaceutical Co ltd
Publication of CN116323638A publication Critical patent/CN116323638A/zh
Pending legal-status Critical Current

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
CN202180064601.7A 2020-07-22 2021-07-22 订书钉化肽及其方法 Pending CN116323638A (zh)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US202063055308P 2020-07-22 2020-07-22
US63/055,308 2020-07-22
US202163208494P 2021-06-08 2021-06-08
US63/208,494 2021-06-08
PCT/US2021/042856 WO2022020652A2 (en) 2020-07-22 2021-07-22 Stapled peptides and methods thereof

Publications (1)

Publication Number Publication Date
CN116323638A true CN116323638A (zh) 2023-06-23

Family

ID=79728982

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202180064601.7A Pending CN116323638A (zh) 2020-07-22 2021-07-22 订书钉化肽及其方法

Country Status (10)

Country Link
US (1) US20240116985A1 (cg-RX-API-DMAC10.html)
EP (1) EP4185599A4 (cg-RX-API-DMAC10.html)
JP (1) JP2023535026A (cg-RX-API-DMAC10.html)
KR (1) KR20230057350A (cg-RX-API-DMAC10.html)
CN (1) CN116323638A (cg-RX-API-DMAC10.html)
AU (1) AU2021314310A1 (cg-RX-API-DMAC10.html)
CA (1) CA3186681A1 (cg-RX-API-DMAC10.html)
IL (1) IL299907A (cg-RX-API-DMAC10.html)
MX (1) MX2023000947A (cg-RX-API-DMAC10.html)
WO (1) WO2022020652A2 (cg-RX-API-DMAC10.html)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR112020004555A2 (pt) 2017-09-07 2020-09-24 Fog Pharmaceuticals, Inc. agentes que modulam funções de beta-catenina e métodos dos mesmos
AU2019326423A1 (en) 2018-08-20 2021-04-08 Fog Pharmaceuticals, Inc. Collections of peptides, peptide agents, and methods of use thereof
BR112023025528A2 (pt) * 2021-06-08 2024-02-27 Fog Pharmaceuticals Inc Peptídeos grampeados e métodos destes
CN115260060A (zh) * 2022-09-07 2022-11-01 康化(上海)新药研发有限公司 (2s)-2-n-芴甲氧羰基氨基-5,5-二甲基正亮氨酸的合成方法
WO2024054892A1 (en) * 2022-09-09 2024-03-14 Shape Therapeutics Inc. Therapeutic peptides
US20260207704A1 (en) * 2022-12-15 2026-07-23 Parabilis Medicines, Inc. Stapled peptides and methods thereof
WO2024130217A1 (en) * 2022-12-15 2024-06-20 Fog Pharmaceuticals, Inc. Stapled peptides and methods thereof

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU5671196A (en) * 1996-03-28 1997-10-17 Immulogic Pharmaceutical Corporation Myelin oligodendrocyte glycoprotein peptides and uses thereof
US20040181830A1 (en) * 2001-05-07 2004-09-16 Kovalic David K. Nucleic acid molecules and other molecules associated with plants and uses thereof for plant improvement
US20050187147A1 (en) * 2003-09-22 2005-08-25 Newman Michael J. Compositions and methods for increasing drug efficiency
WO2009106073A2 (en) * 2008-02-28 2009-09-03 Dako Denmark A/S Mhc multimers in borrelia diagnostics and disease
KR101706789B1 (ko) * 2008-07-21 2017-02-14 프로비오드룩 아게 진단용 항체 검사법
WO2010037395A2 (en) * 2008-10-01 2010-04-08 Dako Denmark A/S Mhc multimers in cancer vaccines and immune monitoring
WO2012040459A2 (en) * 2010-09-22 2012-03-29 President And Fellows Of Harvard College Beta-catenin targeting peptides and uses thereof
WO2014026033A1 (en) * 2012-08-08 2014-02-13 University Of Florida Research Foundation, Inc. Cross-reactive t cell epitopes of hiv, siv, and fiv for vaccines in humans and cats
GB2563875B (en) * 2017-06-28 2020-08-19 Sutura Therapeutics Ltd Improvements in drug delivery
BR112020004555A2 (pt) * 2017-09-07 2020-09-24 Fog Pharmaceuticals, Inc. agentes que modulam funções de beta-catenina e métodos dos mesmos
EP3765852A1 (en) * 2018-03-14 2021-01-20 Dana Farber Cancer Institute, Inc. Stabilized peptides for biomarker detection

Also Published As

Publication number Publication date
WO2022020652A2 (en) 2022-01-27
WO2022020652A3 (en) 2022-03-03
KR20230057350A (ko) 2023-04-28
CA3186681A1 (en) 2022-01-27
JP2023535026A (ja) 2023-08-15
AU2021314310A1 (en) 2023-03-16
US20240116985A1 (en) 2024-04-11
MX2023000947A (es) 2023-02-22
EP4185599A4 (en) 2024-08-28
EP4185599A2 (en) 2023-05-31
IL299907A (en) 2023-03-01

Similar Documents

Publication Publication Date Title
JP2022043073A (ja) 二価ブロモドメインインヒビターおよびそれらの使用
KR20230057350A (ko) 스테이플화된 펩티드 및 이의 방법
US20230128688A1 (en) Directed conjugation technologies
JP2021514958A (ja) 選択的なタンパク質分解を誘導するための低分子およびその使用法
AU2019362788A1 (en) Transcriptional enhanced associate domain (TEAD) transcription factor inhibitors and uses thereof
KR20240031957A (ko) 스테이플화된 펩티드 및 이의 방법
WO2015117083A1 (en) Diazepane derivatives and uses thereof
WO2015117087A1 (en) Uses of diazepane derivatives
JP2019510810A (ja) インドールアミン−2,3−ジオキシゲナーゼ(ido)阻害剤
EP3902542A1 (en) Inhibitors of cyclin-dependent kinase 7 and uses thereof
CN115697415A (zh) 用于预防或治疗感染的技术
JP2024517183A (ja) 転写増強アソシエートドメイン(tead)転写因子阻害剤及びその使用
CN116113621A (zh) 氨基酸
EP4288110A2 (en) Technologies for preventing or treating infections
JP2025541247A (ja) ステープルペプチドおよびその方法
JP2025541246A (ja) ステープルペプチドおよびその方法
WO2024220676A1 (en) Mrna degraders and methods of use thereof
HK40129655A (zh) 订书钉化肽及其方法
HK40108355A (en) Stapled peptides and methods thereof
HK40128981A (zh) 订书钉化肽及其方法
US20240391956A1 (en) Stapled peptides and methods thereof
CN117794560A (zh) 订书钉化肽及其方法
KR20260035134A (ko) 스테이플화 펩티드 및 이의 방법
AU2023418787A1 (en) Naphthylamide compound, and preparation method therefor and use thereof
WO2025265097A1 (en) Stapled peptides and methods thereof

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
CB02 Change of applicant information
CB02 Change of applicant information

Country or region after: U.S.A.

Address after: Massachusetts, USA

Applicant after: Paris Pharmaceutical Co.

Address before: Massachusetts, USA

Applicant before: Vogel Pharmaceutical Co.,Ltd.

Country or region before: U.S.A.